F/m Compoundr U.S. Aggregate Bond ETF (CPAG)
Live price chart, market sentiment, and community perspectives for F/m Compoundr U.S. Aggregate Bond ETF (NASDAQ: CPAG).
Live price chart, market sentiment, and community perspectives for F/m Compoundr U.S. Aggregate Bond ETF (NASDAQ: CPAG).
On our desk, evaluating CPAG comes down to a trade-off between structural tax optimization and fee efficiency. The fund aims to help investors control the timing and character of taxable income while achieving 100% reinvestment without immediate distribution drag. However, charging 0.31% to hold an underlying asset like AGG—which trades at a mere 0.03% expense ratio—creates a notable hurdle for cost-conscious investors. When you look at institutional participation, we saw 14 hedge funds and large institutions holding $8.69M in Q1 2026, but overall institutional ownership shifted significantly. While it offers a neat mechanical solution for tax-deferred compounding, clients must weigh whether the wrapper justifies the added basis points.
Reviewing the risk profile of CPAG reveals a mixed narrative. The fund holds an effective duration of 5.80 years and a yield-to-maturity of 4.74%, backed by a Federal Reserve policy rate holding at 5.25%–5.50%. Yet, Morningstar peer ratings point to a low return profile versus the intermediate core bond category. Furthermore, the 1-year beta of 0.13 confirms it decouples from equities, matching its intermediate mandate, but the thin daily dollar volume of approximately $127K adds execution friction. The drawdown and Sharpe metrics reflect a challenging historical window for fixed income, demanding careful portfolio integration.
When analyzing CPAG for quantitative and tracking efficiency, I focus heavily on its operational mechanics since its August 12, 2025 inception. The fund mirrors the Nasdaq Compoundr U.S. Aggregate Bond Index by holding roughly 100% of the iShares Core US Aggregate Bond ETF (AGG). Because of this wrapper design, it behaves similarly to traditional aggregate bond exposures while utilizing specific distribution structures to bypass immediate coupon tax drag. Analysts must monitor its tracking error closely, especially given its short operating history, where YTD NAV returns slightly lagged the index during minor adjustment windows.
Explore plasma cleansing, somatic organ swaps, and BCI.